Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program.

Heinemann L, Schramm W, Koenig H, Moritz A, Vesper I, Weissmann J, Kulzer B.

J Diabetes Sci Technol. 2019 Aug 5:1932296819867686. doi: 10.1177/1932296819867686. [Epub ahead of print]

PMID:
31378074
2.

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Kent S, Becker F, Feenstra T, Tran-Duy A, Schlackow I, Tew M, Zhang P, Ye W, Lizheng S, Herman W, McEwan P, Schramm W, Gray A, Leal J, Lamotte M, Willis M, Palmer AJ, Clarke P.

Pharmacoeconomics. 2019 Jul 26. doi: 10.1007/s40273-019-00825-1. [Epub ahead of print]

PMID:
31347104
3.

Current Trend of Invasive Orthopaedic Interventions for People with Haemophilia in Romania: Single Centre Experience.

Serban M, Poenaru DV, Patrascu JM, Ritli L, Boia E, Mihailov DM, Ursu CE, Savescu D, Ionita I, Traila A, Cerbu S, Boeriu E, Jinca C, Schramm W, Arghirescu S.

Hamostaseologie. 2019 Feb 13. doi: 10.1055/s-0039-1677884. [Epub ahead of print]

PMID:
30759481
4.

Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.

Kulzer B, Daenschel W, Daenschel I, Schramm W, Messinger D, Weissmann J, Vesper I, Parkin CG, Heinemann L.

Diabetes Res Clin Pract. 2018 Oct;144:200-212. doi: 10.1016/j.diabres.2018.09.002. Epub 2018 Sep 8.

5.

Digital Diabetes Self-Management: A Trilateral Serial.

Schramm W.

J Diabetes Sci Technol. 2018 May;12(3):709-711. doi: 10.1177/1932296818761973. Epub 2018 Mar 7.

6.

Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary data.

Schopohl D, Bidlingmaier C, Herzig D, Klamroth R, Kurnik K, Rublee D, Schramm W, Schwarzkopf L, Berger K.

Haemophilia. 2018 Jul;24(4):584-594. doi: 10.1111/hae.13443. Epub 2018 Feb 28.

PMID:
29488669
7.

Healthy, Sick, Dead - An Educational Blueprint to State Transition Disease Modelling.

Schramm W, Rickmann J, Sailer F.

Stud Health Technol Inform. 2017;238:223-226.

PMID:
28679929
8.

Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.

Giangrande PLF, Peyvandi F, O'Mahony B, Behr-Gross ME, Hilger A, Schramm W, Mannucci PM.

Haemophilia. 2017 May;23(3):370-375. doi: 10.1111/hae.13211. Epub 2017 Apr 12.

9.

Wishes and worries of haemophilia patients. A patient survey from Bavaria.

Lechner H, Schleiermacher A, Berger K, Schopohl D, Schramm W.

Hamostaseologie. 2017 May 10;37(2):117-126. doi: 10.5482/HAMO-16-09-0033. Epub 2017 Apr 10.

PMID:
28393961
10.

Retromolar laryngoscopy: a randomized crossover vocal cords visualization study.

Reiterer C, Waltl B, Kabon B, Schramm W.

Minerva Anestesiol. 2017 Aug;83(8):798-803. doi: 10.23736/S0375-9393.17.11537-3. Epub 2017 Jan 17.

11.

Wishes and worries of haemophilia patients.

Lechner H, Schleiermacher A, Berger K, Schopohl D, Schramm W.

Hamostaseologie. 2017;37(2):117-126. doi: 10.5482/HAMO-16-09-0033. Epub 2017 Dec 28.

PMID:
29582908
12.

Blood Product Supply in Germany: The Impact of Apheresis and Pooled Platelet Concentrates.

Berger K, Schopohl D, Wittmann G, Schramm W, Ostermann H, Rieger C.

Transfus Med Hemother. 2016 Nov;43(6):389-394. Epub 2016 Sep 15.

13.

Clinical Cancer Registries - Are They Up for Health Services Research?

Pobiruchin M, Bochum S, Martens UM, Schramm W.

Stud Health Technol Inform. 2016;228:242-6.

PMID:
27577380
14.

PROSIT Open Source Disease Models for Diabetes Mellitus.

Schramm W, Sailer F, Pobiruchin M, Weiss C.

Stud Health Technol Inform. 2016;226:115-8.

PMID:
27350481
15.

Transition probabilities of HER2-positive and HER2-negative breast cancer patients treated with Trastuzumab obtained from a clinical cancer registry dataset.

Pobiruchin M, Bochum S, Martens UM, Kieser M, Schramm W.

Data Brief. 2016 Mar 12;7:654-7. doi: 10.1016/j.dib.2016.03.039. eCollection 2016 Jun.

16.

Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed.

Berger KC, Feldman BM, Wasserman J, Schramm W, Blanchette V, Fischer K; Outcome Measures Expert Working Group of the International Prophylaxis Study Group (IPSG).

Haematologica. 2016 Mar;101(3):266-8. doi: 10.3324/haematol.2015.139931. No abstract available.

17.

A method for using real world data in breast cancer modeling.

Pobiruchin M, Bochum S, Martens UM, Kieser M, Schramm W.

J Biomed Inform. 2016 Apr;60:385-94. doi: 10.1016/j.jbi.2016.01.017. Epub 2016 Feb 8.

18.

Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.

Kulzer B, Daenschel W, Daenschel I, Siegel EG, Schramm W, Parkin CG, Messinger D, Weissmann J, Djuric Z, Mueller A, Vesper I, Heinemann L.

J Diabetes Sci Technol. 2016 May 3;10(3):772-81. doi: 10.1177/1932296815617487. Print 2016 May.

19.

Prediction of 5-Year Survival with Data Mining Algorithms.

Sailer F, Pobiruchin M, Bochum S, Martens UM, Schramm W.

Stud Health Technol Inform. 2015;213:75-8.

PMID:
26152957
20.

Research in haemophilia B--approaching the request for high evidence levels in a rare disease.

Berger K, Schopohl D, Hilger A, Behr Gross ME, Giangrande P, Peyvandi F, Seitz R, Schramm W.

Haemophilia. 2015 Jan;21(1):4-20. doi: 10.1111/hae.12603. Epub 2014 Dec 11. Review.

PMID:
25495927
21.

A New Method of Airway Management in Patients Undergoing Gasserian Ganglion Thermal Coagulation: Preliminary Results.

Klug W, Reiterer C, Bukaty A, Schramm W.

J Neurosurg Anesthesiol. 2015 Jul;27(3):252-6. doi: 10.1097/ANA.0000000000000139.

PMID:
25437813
22.

Risks and challenges of orthopaedic invasive interventions in haemophilia in a low-resource country. A single-center experience.

Serban M, Poenaru D, Patrascu J, Ursu E, Savescu D, Ionita H, Jinca C, Pop L, Talpos-Niculescu S, Ritli L, Arghirescu S, Mihailov D, Schramm W.

Hamostaseologie. 2014;34 Suppl 1:S30-5. doi: 10.5482/HAMO-14-01-0007.

PMID:
25382767
23.

[Prophylactic factor substitution in severe haemophilia A. Economic assessment in adult patients].

Berger K, Schopohl D, Eheberg D, Oldenburg J, Tiede A, Schramm W.

Hamostaseologie. 2014;34(4):291-300. doi: 10.5482/HAMO-14-03-0017. German.

PMID:
25370177
24.

Computerized in vivo classification of methylene blue stained fallopian tube mucosal damage: preliminary results.

Anker B, Brandstätter M, Sliutz G, Watrelot A, Wierrani F, Schramm W.

Clin Exp Obstet Gynecol. 2014;41(4):389-93.

PMID:
25134282
25.

Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.

Giangrande P, Seitz R, Behr-Gross ME, Berger K, Hilger A, Klein H, Schramm W, Mannucci PM.

Haemophilia. 2014 May;20(3):322-5. doi: 10.1111/hae.12440.

PMID:
24731129
26.

Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity.

Matino D, Lillicrap D, Astermark J, Dolan G, Kessler C, Lambert T, Makris M, O'Donnell J, Pipe S, Santagostino E, Saint-Remy JM, Schramm W, Iorio A.

Haemophilia. 2014 Mar;20(2):200-6. doi: 10.1111/hae.12283. Epub 2013 Oct 29.

27.

The history of haemophilia - a short review.

Schramm W.

Thromb Res. 2014 Nov;134 Suppl 1:S4-9. doi: 10.1016/j.thromres.2013.10.020. Epub 2014 Feb 7. Review.

PMID:
24513149
28.

Morbidity and mortality of haemophilia patients in Germany. Survey results 2011/2012.

Schramm W, Rieger A.

Hamostaseologie. 2013;33 Suppl 1:S5-9.

PMID:
24170073
29.

[New data from the German Haemophilia Registry].

Hesse J, Haschberger B, Heiden M, Seitz R, Schramm W.

Hamostaseologie. 2013;33 Suppl 1:S15-21. German.

PMID:
24169687
30.

Leveraging Markov models to compute prevalence estimates for a regional breast cancer registry.

Pobiruchin M, Kieser M, Schramm W.

Stud Health Technol Inform. 2013;190:237-9.

PMID:
23823434
31.

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.

Gringeri A, Leissinger C, Cortesi PA, Jo H, Fusco F, Riva S, Antmen B, Berntorp E, Biasoli C, Carpenter S, Kavakli K, Morfini M, Négrier C, Rocino A, Schramm W, Windyga J, Zülfikar B, Mantovani LG.

Haemophilia. 2013 Sep;19(5):736-43. doi: 10.1111/hae.12178. Epub 2013 Jun 4.

PMID:
23731246
32.

Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for Germany.

Berger K, Schopohl D, Eheberg D, Auerswald G, Kurnik K, Schramm W.

Klin Padiatr. 2013 May;225(3):152-8. doi: 10.1055/s-0033-1334929. Epub 2013 Mar 21.

PMID:
23519749
33.

[Regional analysis of drug treatment prevalence and medication of diabetes mellitus in Germany].

Willert T, Walker J, Schramm W.

Dtsch Med Wochenschr. 2012 Nov;137(46):2363-8. doi: 10.1055/s-0032-1327273. Epub 2012 Nov 6. German.

PMID:
23132154
34.

[Morbidity and mortality of patients with haemophilia in Germany--update 2010/2011].

Schramm W, Rieger A; Teilnehmende Behandlungseinrichtungen.

Hamostaseologie. 2012;32 Suppl 1:S5-11. German.

PMID:
22961446
35.

Long-term outcome of an unusual haemophilic pseudotumour.

Serban M, Mihailov D, Savescu D, Bordos D, Talpos Niculescu S, Jinca C, Lăcătuşu A, Siebeck M, Schramm W.

Hamostaseologie. 2012;32 Suppl 1:S43-4.

PMID:
22960649
36.

Self-monitoring of blood glucose: one STeP forward?

Schramm W.

J Diabetes Sci Technol. 2012 Jul 1;6(4):978-82. Review.

37.

Haemophilia care in Europe: the ESCHQoL study.

Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, Giangrande PL, Von Mackensen S, Mantovani LG, Nemes L, Serban M; ESCHQOL Study Group.

Haemophilia. 2012 Sep;18(5):729-37. doi: 10.1111/j.1365-2516.2012.02847.x. Epub 2012 May 29.

PMID:
22639833
38.

Management of bleeding disorders in the elderly.

Kruse-Jarres R, Quon D, Schramm W, Dolan G.

Haemophilia. 2012 May;18 Suppl 2:37-45. doi: 10.1111/j.1365-2516.2012.02798.x.

PMID:
22530577
39.

Haemophilia prophylaxis: how can we justify the costs?

Feldman BM, Berger K, Bohn R, Carcao M, Fischer K, Gringeri A, Hoots K, Mantovani L, Willan AR, Schramm W.

Haemophilia. 2012 Sep;18(5):680-4. doi: 10.1111/j.1365-2516.2012.02790.x. Epub 2012 Apr 17. Review.

PMID:
22507524
40.

Haemophilia patients with HIV- and HCV-infection. Long term survival.

Schneider MM, Shows A, Giebl A, Schramm W.

Hamostaseologie. 2011 Nov;31 Suppl 1:S14-9.

PMID:
22057841
41.

Development of inhibitors in haemophilia. Ongoing epidemiological study.

Serban M, Mihailov D, Pop L, Ionita H, Ursu E, Talpos-Niculescu S, Ritli L, Baghiu D, Uscatescu V, Petrovanu C, Stancu P, Savescu D, Cucuianu A, Schramm W.

Hamostaseologie. 2011 Nov;31 Suppl 1:S20-3.

PMID:
22057218
42.

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors.

Leissinger C, Gringeri A, Antmen B, Berntorp E, Biasoli C, Carpenter S, Cortesi P, Jo H, Kavakli K, Lassila R, Morfini M, Négrier C, Rocino A, Schramm W, Serban M, Uscatescu MV, Windyga J, Zülfikar B, Mantovani L.

N Engl J Med. 2011 Nov 3;365(18):1684-92. doi: 10.1056/NEJMoa1104435. Erratum in: N Engl J Med. 2011 Dec 22;365(25):2441.

43.

Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany.

Paessens B, Ihbe-Heffinger A, von Schilling C, Shlaen R, Bernard R, Peschel C, Schramm W, Berger K.

Support Care Cancer. 2012 May;20(5):1011-21. doi: 10.1007/s00520-011-1173-1. Epub 2011 May 12.

PMID:
21562801
44.

The Wildbad Kreuth initiative: European current practices and recommendations for optimal use of blood components.

Berger K, Klein HG, Seitz R, Schramm W, Spieser JM.

Biologicals. 2011 May;39(3):189-93. doi: 10.1016/j.biologicals.2011.03.002. Epub 2011 Apr 23.

PMID:
21524591
45.

The ancient and often incorrect units for the ventricular stroke work should be replaced by an SI unit.

Schramm W, Notley B.

Am Heart J. 2011 Mar;161(3):e9; author reply e11. doi: 10.1016/j.ahj.2010.11.015. No abstract available.

PMID:
21392594
46.

Gram meter and the right ventricular stroke work.

Meitner E, Schramm W.

Minerva Anestesiol. 2010 Nov;76(11):967-8; author reply 969. No abstract available.

47.

[Documentation of haemophilia treatment supported by the German Hemophilia Registry].

Haschberger B, Hesse J, Heiden M, Seitz R, Schramm W.

Hamostaseologie. 2010 Nov;30 Suppl 1:S62-4. German.

PMID:
21042680
48.

[A quarter century of psychosocial haemophilia-counseling].

Schneider MM, Schramm W.

Hamostaseologie. 2010 Nov;30 Suppl 1:S19-22. German.

PMID:
21042670
49.

[Haemophilia patients in Germany 2008/2009. Morbidity and mortality].

Schramm W, Krebs H.

Hamostaseologie. 2010 Nov;30 Suppl 1:S9-S14. German.

PMID:
21042661
50.

A fictive unit for the cardiac work for at least 83 years.

Marschalek C, Schramm W.

Nitric Oxide. 2010 Dec 15;23(4):343. doi: 10.1016/j.niox.2010.07.005. Epub 2010 Jul 25. No abstract available.

PMID:
20667481

Supplemental Content

Loading ...
Support Center